Many ex-FDA drug reviewers take ‘revolving door’ to pharma industry
Oregon Health & Science University researchers published their findings Tuesday in The BMJ.
Oregon Health & Science University researchers published their findings Tuesday in The BMJ.
Critics say getting generic alternatives to the U.S. market for products like EpiPen is still taking far too long.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.